We have compiled the most common questions here so please review and contact us if you have any other questions.
ADDITIONAL QUESTIONS
Answers to regular questions
So unlike the typical trial advert which has condition/TA, age, medical status and more and a phone number and email – what people see with AI-MAtch is an invitation to search on the Platform for a study that’s right for them.[/rt_accordion_style_item][rt_accordion_style_item accordion_item_title=”Why doesn’t AI-Match Platform collect patient details and build databases of patients?”]We decided very early on that patient privacy is paramount and no amount of security could protect such as database. So instead we chose to find people “in the moment” when they are online searching and commenting or purchasing medical supplies/equipment or on social media. This way we find the most motivated and active patients. Also, people’s health status and information on databases can quickly be out of date or not relevant. In addition, increasingly people are not wanting to share their information and health status and be kept on a database that may or may not be secure.
So unlike all other online recruitment companies, we never ask for ID information until we find a study for them, and only so we can send on to their chosen clinic – we are very clear we don’t keep their information which means more people join studies via AI-Match Platform.[/rt_accordion_style_item][rt_accordion_style_item accordion_item_title=”How many studies has AI-Match Platform recruited for?”]The AI-Match Platform has recruited successfully for 462 trials across the US, APAC and EU.[/rt_accordion_style_item][rt_accordion_style_item accordion_item_title=”What is the AI-Match Platform success rate?”]Our data shows:
- 78% of trial rescue studies are fully recruited within the time allocated.
- 92% of trials that start with AI-Match Platform from the beginning recruit successfully on time and budget.
Each study starts with a patient persona and we collect as much data as possible about the type of people we are targeting. This informs our algorithms and AI-Match screener.
This means we can instantly recruit for rare diseases through to the more common metabolic and dermatological studies.[/rt_accordion_style_item][/rt_accordion_style]